NEUP
Price
$12.16
Change
+$1.94 (+18.98%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
22.95M
SYBX
Price
$1.45
Change
-$0.01 (-0.68%)
Updated
Aug 28 closing price
Capitalization
16.96M
Interact to see
Advertisement

NEUP vs SYBX

Header iconNEUP vs SYBX Comparison
Open Charts NEUP vs SYBXBanner chart's image
Neuphoria Therapeutics
Price$12.16
Change+$1.94 (+18.98%)
Volume$1.99K
Capitalization22.95M
Synlogic
Price$1.45
Change-$0.01 (-0.68%)
Volume$5.52K
Capitalization16.96M
NEUP vs SYBX Comparison Chart in %
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SYBX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Buy and SYBX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (NEUP: $12.21 vs. SYBX: $1.45)
Brand notoriety: NEUP and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 378% vs. SYBX: 9%
Market capitalization -- NEUP: $22.95M vs. SYBX: $16.96M
NEUP [@Biotechnology] is valued at $22.95M. SYBX’s [@Biotechnology] market capitalization is $16.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 0 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 0 green, 5 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, NEUP is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 4 TA indicator(s) are bullish while SYBX’s TA Score has 5 bullish TA indicator(s).

  • NEUP’s TA Score: 4 bullish, 5 bearish.
  • SYBX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SYBX is a better buy in the short-term than NEUP.

Price Growth

NEUP (@Biotechnology) experienced а +76.45% price change this week, while SYBX (@Biotechnology) price change was +3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($23M) has a higher market cap than SYBX($17M). SYBX has higher P/E ratio than NEUP: SYBX (6.36) vs NEUP (0.65). NEUP YTD gains are higher at: 197.959 vs. SYBX (3.571). NEUP has higher annual earnings (EBITDA): 192K vs. SYBX (-11.07M). NEUP (17M) and SYBX (17M) have equal amount of cash in the bank . SYBX has less debt than NEUP: SYBX (0) vs NEUP (172K). NEUP has higher revenues than SYBX: NEUP (15.7M) vs SYBX (0).
NEUPSYBXNEUP / SYBX
Capitalization23M17M135%
EBITDA192K-11.07M-2%
Gain YTD197.9593.5715,543%
P/E Ratio0.656.3610%
Revenue15.7M0-
Total Cash17M17M100%
Total Debt172K0-
FUNDAMENTALS RATINGS
SYBX: Fundamental Ratings
SYBX
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPSYBX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH24.810.57
+2.35%
Dianthus Therapeutics
OXSQ2.200.01
+0.46%
Oxford Square Capital Corp
CNO39.42-0.19
-0.48%
CNO Financial Group
WEC106.31-1.37
-1.27%
WEC Energy Group
ORKT0.70-0.01
-1.42%
Orangekloud Technology Inc

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+23.58%
SYBX - NEUP
64%
Loosely correlated
N/A
BRNS - NEUP
50%
Loosely correlated
-4.19%
SLGL - NEUP
41%
Loosely correlated
-6.60%
CMND - NEUP
34%
Loosely correlated
+0.99%
ENSC - NEUP
31%
Poorly correlated
+0.97%
More